Title of Collaborative Activity:
Interagency Group on SARS-CoV-2 Evolution and Vaccine Cadence
Description of Collaborative Activity:
An interagency group convened to monitor SARS-CoV-2 evolution and advise on appropriate timing of vaccine and booster delivery.
Type of Collaborative Activity:
Committee, Advisory Group, or Work Group
Year the Collaborative Activity Originated:
NIH Participating Institutes/Centers/Office of the Director:
NIAID
HHS Agency Collaborators on this Activity:
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, HIS, SAMHSA
